CA Stock MarketDetailed Quotes

EPRX Eupraxia Pharmaceuticals Inc

Watchlist
  • 3.700
  • +0.220+6.32%
15min DelayMarket Closed Aug 9 16:00 ET
131.80MMarket Cap-2908P/E (TTM)

Eupraxia Pharmaceuticals Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
61.81%23.32M
--35.91M
5.90%19.34M
5.90%19.34M
11.46%24.43M
-47.63%14.41M
-22.12%18.26M
-22.12%18.26M
-16.95%21.92M
-5.43%27.52M
-Cash and cash equivalents
61.81%23.32M
--35.91M
5.90%19.34M
5.90%19.34M
183.07%24.43M
6.75%14.41M
11.46%18.26M
11.46%18.26M
-67.30%8.63M
-53.61%13.5M
-Accounts receivable
--13.57K
----
----
----
--1.49K
----
----
----
----
----
-Other receivables
--5M
--5M
--5M
--5M
----
----
----
----
----
----
Total current assets
64.69%24.53M
--36.22M
6.53%19.8M
6.53%19.8M
10.37%24.85M
-47.28%14.89M
-22.55%18.59M
-22.55%18.59M
-16.14%22.51M
-4.99%28.25M
Non current assets
-Accumulated depreciation
-23.76%-422.34K
---413.37K
-35.95%-398.07K
-35.95%-398.07K
-39.26%-360.3K
-39.01%-341.25K
-18.68%-292.81K
-18.68%-292.81K
-15.58%-258.73K
28.27%-245.49K
-Long term equity investment
-21.63%34.95K
----
--0
--0
-99.88%8.67K
-99.42%44.6K
20.11%8.86M
20.11%8.86M
2.25%7.4M
8.00%7.65M
-Other intangible assets
----
----
----
----
--15.96M
--13.81M
----
----
----
----
Regulatory assets
200.56%155.24K
--167.24K
112.46%190.61K
112.46%190.61K
-76.25%67.84K
-82.33%51.65K
-73.38%89.72K
-73.38%89.72K
255.86%285.62K
795.40%292.28K
Total assets
302.55%141.67K
--167.24K
151.39%190.61K
151.39%190.61K
59.43%58.51K
-1.59%35.19K
242.80%75.82K
242.80%75.82K
-12.92%36.7K
87.26%35.76K
Liabilities
Current liabilities
Current debt and capital lease obligation
-44.66%4.63M
--9.56M
7,951.11%10.45M
7,951.11%10.45M
8,835.96%11.33M
6,489.65%8.36M
6.93%129.82K
6.93%129.82K
6.40%126.81K
179.77%126.82K
-Current debt
-45.15%4.55M
--9.52M
12,993.65%10.4M
12,993.65%10.4M
14,279.08%11.28M
10,669.04%8.3M
6.68%79.42K
6.68%79.42K
6.44%78.42K
--77.09K
-Current capital lease obligation
29.62%71.01K
--37.85K
5.78%53.32K
5.78%53.32K
13.67%55K
10.16%54.78K
7.32%50.4K
7.32%50.4K
6.32%48.39K
9.70%49.73K
-Total tax payable
-21.63%34.95K
--0
--0
--0
-99.88%8.67K
-99.42%44.6K
20.11%8.86M
20.11%8.86M
2.25%7.4M
8.00%7.65M
Current accrued expenses
-25.66%1.98M
--3.38M
25.32%3.03M
25.32%3.03M
87.41%2.85M
-0.01%2.66M
124.87%2.42M
124.87%2.42M
-27.97%1.52M
333.99%2.66M
Current liabilities
5.31%11.6M
--18.53M
533.47%19.37M
533.47%19.37M
760.76%14.18M
295.26%11.02M
71.95%3.06M
71.95%3.06M
-26.14%1.65M
323.38%2.79M
Non current liabilities
-Long term debt
49.31%34.95K
----
--0
--0
-86.29%8.67K
-70.89%23.41K
-52.51%51.3K
-52.51%51.3K
-45.60%63.29K
-40.90%80.42K
Non current accrued expenses
-3.36%445.53K
--414.85K
-14.04%456.25K
-14.04%456.25K
-13.24%422.11K
-10.61%461K
14.88%530.75K
14.88%530.75K
1.34%486.54K
128.44%515.71K
Long term provisions
----
----
----
----
----
-99.72%21.19K
21.19%8.8M
21.19%8.8M
3.03%7.33M
8.96%7.57M
Preferred securities outside stock equity
--0
--550.95K
67.28%858.63K
67.28%858.63K
--0
--0
-11.98%513.3K
-11.98%513.3K
--0
----
Total non current liabilities
5.20%11.64M
--18.53M
62.61%19.37M
62.61%19.37M
56.88%14.19M
5.97%11.06M
30.18%11.91M
30.18%11.91M
-4.44%9.05M
34.82%10.44M
Shareholders'equity
Share capital
55.12%116.32M
--116.32M
30.86%92.91M
30.86%92.91M
29.29%86.85M
5.17%74.98M
12.16%71M
12.16%71M
6.10%67.17M
9.47%71.3M
-common stock
55.12%116.32M
--116.32M
30.86%92.91M
30.86%92.91M
29.29%86.85M
5.17%74.98M
12.16%71M
12.16%71M
6.10%67.17M
9.47%71.3M
Additional paid-in capital
--18.98M
--17.51M
3.92%17.51M
3.92%17.51M
----
----
55.00%16.85M
55.00%16.85M
19.49%12.48M
25.41%13.04M
Gains losses not affecting retained earnings
---2.92M
---2.74M
2.86%-2.71M
2.86%-2.71M
----
----
---2.79M
---2.79M
----
----
Total equity
62.63%24.98M
--36.64M
5.98%20.27M
5.98%20.27M
9.89%25.27M
-46.61%15.36M
-21.91%19.12M
-21.91%19.12M
-15.97%23M
-3.98%28.76M
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments 61.81%23.32M--35.91M5.90%19.34M5.90%19.34M11.46%24.43M-47.63%14.41M-22.12%18.26M-22.12%18.26M-16.95%21.92M-5.43%27.52M
-Cash and cash equivalents 61.81%23.32M--35.91M5.90%19.34M5.90%19.34M183.07%24.43M6.75%14.41M11.46%18.26M11.46%18.26M-67.30%8.63M-53.61%13.5M
-Accounts receivable --13.57K--------------1.49K--------------------
-Other receivables --5M--5M--5M--5M------------------------
Total current assets 64.69%24.53M--36.22M6.53%19.8M6.53%19.8M10.37%24.85M-47.28%14.89M-22.55%18.59M-22.55%18.59M-16.14%22.51M-4.99%28.25M
Non current assets
-Accumulated depreciation -23.76%-422.34K---413.37K-35.95%-398.07K-35.95%-398.07K-39.26%-360.3K-39.01%-341.25K-18.68%-292.81K-18.68%-292.81K-15.58%-258.73K28.27%-245.49K
-Long term equity investment -21.63%34.95K------0--0-99.88%8.67K-99.42%44.6K20.11%8.86M20.11%8.86M2.25%7.4M8.00%7.65M
-Other intangible assets ------------------15.96M--13.81M----------------
Regulatory assets 200.56%155.24K--167.24K112.46%190.61K112.46%190.61K-76.25%67.84K-82.33%51.65K-73.38%89.72K-73.38%89.72K255.86%285.62K795.40%292.28K
Total assets 302.55%141.67K--167.24K151.39%190.61K151.39%190.61K59.43%58.51K-1.59%35.19K242.80%75.82K242.80%75.82K-12.92%36.7K87.26%35.76K
Liabilities
Current liabilities
Current debt and capital lease obligation -44.66%4.63M--9.56M7,951.11%10.45M7,951.11%10.45M8,835.96%11.33M6,489.65%8.36M6.93%129.82K6.93%129.82K6.40%126.81K179.77%126.82K
-Current debt -45.15%4.55M--9.52M12,993.65%10.4M12,993.65%10.4M14,279.08%11.28M10,669.04%8.3M6.68%79.42K6.68%79.42K6.44%78.42K--77.09K
-Current capital lease obligation 29.62%71.01K--37.85K5.78%53.32K5.78%53.32K13.67%55K10.16%54.78K7.32%50.4K7.32%50.4K6.32%48.39K9.70%49.73K
-Total tax payable -21.63%34.95K--0--0--0-99.88%8.67K-99.42%44.6K20.11%8.86M20.11%8.86M2.25%7.4M8.00%7.65M
Current accrued expenses -25.66%1.98M--3.38M25.32%3.03M25.32%3.03M87.41%2.85M-0.01%2.66M124.87%2.42M124.87%2.42M-27.97%1.52M333.99%2.66M
Current liabilities 5.31%11.6M--18.53M533.47%19.37M533.47%19.37M760.76%14.18M295.26%11.02M71.95%3.06M71.95%3.06M-26.14%1.65M323.38%2.79M
Non current liabilities
-Long term debt 49.31%34.95K------0--0-86.29%8.67K-70.89%23.41K-52.51%51.3K-52.51%51.3K-45.60%63.29K-40.90%80.42K
Non current accrued expenses -3.36%445.53K--414.85K-14.04%456.25K-14.04%456.25K-13.24%422.11K-10.61%461K14.88%530.75K14.88%530.75K1.34%486.54K128.44%515.71K
Long term provisions ---------------------99.72%21.19K21.19%8.8M21.19%8.8M3.03%7.33M8.96%7.57M
Preferred securities outside stock equity --0--550.95K67.28%858.63K67.28%858.63K--0--0-11.98%513.3K-11.98%513.3K--0----
Total non current liabilities 5.20%11.64M--18.53M62.61%19.37M62.61%19.37M56.88%14.19M5.97%11.06M30.18%11.91M30.18%11.91M-4.44%9.05M34.82%10.44M
Shareholders'equity
Share capital 55.12%116.32M--116.32M30.86%92.91M30.86%92.91M29.29%86.85M5.17%74.98M12.16%71M12.16%71M6.10%67.17M9.47%71.3M
-common stock 55.12%116.32M--116.32M30.86%92.91M30.86%92.91M29.29%86.85M5.17%74.98M12.16%71M12.16%71M6.10%67.17M9.47%71.3M
Additional paid-in capital --18.98M--17.51M3.92%17.51M3.92%17.51M--------55.00%16.85M55.00%16.85M19.49%12.48M25.41%13.04M
Gains losses not affecting retained earnings ---2.92M---2.74M2.86%-2.71M2.86%-2.71M-----------2.79M---2.79M--------
Total equity 62.63%24.98M--36.64M5.98%20.27M5.98%20.27M9.89%25.27M-46.61%15.36M-21.91%19.12M-21.91%19.12M-15.97%23M-3.98%28.76M

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg